MASTERKEY-265: A phase III, randomized, placebo (Pbo)-controlled study of talimogene laherparepvec (T) plus pembrolizumab (P) for unresectable stage IIIB-IVM1c melanoma (MEL)

被引：33

作者：

Ribas, A. ^{[1
]}

Chesney, J. ^{[2
]}

Long, G. V. ^{[3
]}

Kirkwood, J. M. ^{[4
]}

Dummer, R. ^{[5
]}

Puzanov, I. ^{[6
]}

Hoeller, C. ^{[7
]}

Gajewski, T. F. ^{[8
]}

Gutzmer, R. ^{[9
]}

Rutkowski, P. ^{[10
]}

Demidov, L. ^{[11
]}

Arenberger, P. ^{[12
]}

Shin, S. J. ^{[13
]}

Ferrucci, P. F. ^{[14
]}

Diede, S. J. ^{[15
]}

Anderson, J. R. ^{[16
]}

Treichel, S. ^{[17
]}

Chan, E. ^{[17
]}

Hodi, F. S. ^{[18
]}

Gogas, H. J. ^{[19
]}

机构：

[1] Univ Calif Los Angeles, Dept Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA

[2] Brown Canc Ctr Univ Louisville, Dept Med Hematol Oncol, Biochem Mol Biol & Pharmacol Toxicol, Louisville, KY USA

[3] Melanoma Inst Australia, Melanoma Med Oncol Translat Res, Wollstonecraft, NSW, Australia

[4] UPMC Hillman Canc Ctr, Melanoma Program, Pittsburgh, PA USA

[5] Univ Zurich, Dept Dermatol, Klin Dermatol, Zurich, Switzerland

[6] Roswell Pk Comprehens Canc Ctr, Dept Med, Buffalo, NY USA

[7] Med Univ Wien, Dept Dermatol & Dermatooncol, Vienna, Austria

[8] Univ Chicago, Ben May Dept Canc Res & Dept Pathol, Chicago, IL USA

[9] Hannover Med Sch, Dermatol Skin Canc Ctr, Dermatol Klin, Hannover, Germany

[10] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland

[11] NN Blokhin Russian Canc Res Ctr, Ctr Canc, Moscow, Russia

[12] Univ Hosp Kralovske Vinohrady, Dermatovenereol Clin, Prague, Czech Republic

[13] Yonsei Univ, Severance Hosp, Coll Med, Seoul, South Korea

[14] IEO Ist Europeo Oncol, Dept Oncol, Milan, Italy

[15] Merck Co & Inc, Oncol Clin Res, MRL Labs, Upper Gwynedd Campus, North Wales, PA USA

[16] Merck & Co Inc, BARDS, Upper Gwynedd Site, North Wales, PA USA

[17] Amgen Headquarters USA, Amgen Ctr Dr, Thousand Oaks, CA USA

[18] Dana Farber Canc Inst, Melanoma Ctr, Boston, MA USA

[19] Natl & Kapodistrian Univ Athens, Med, Athens, Greece

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷

关键词：

D O I：

10.1016/j.annonc.2021.08.1422

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1037O

引用

页码：S868 / S869

页数：2